In chronic myeloid leukemia (CML) and a large fraction of B-cell acute lymphoblastic leukemias, the constitutive tyrosine kinase activity of BCR::ABL1 is the central driver of leukemogenesis35. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.